Wednesday, May 6, 2026

U.S.-South Korea Diplomatic Talks: Can They Resolve Tariff Tensions?

U.S. and South Korea to hold urgent foreign ministers' meeting amid tariff increase tensions, aiming to resolve trade issues.

South Korean Military Strengthens Defense with Full Operationalization of 425 Project Satellites

South Korea's military will launch five reconnaissance satellites by 2025, enhancing capabilities to monitor North Korea's activities.

Elon Musk to Scale Back White House Role, Refocus on Tesla

Elon Musk plans to reduce his role in the U.S. Department of Government Efficiency, focusing more on Tesla amid investor pressure.

Health

CG Bio Group Launches Acellular Dermal Matrix-based Product Reallo Inject Fine

CG Bio launches Reallo Inject Fine, an acellular dermal matrix product, enhancing usability for medical professionals and expanding applications.

Ceragem Launches Global Standard for AI Home Healthcare, Accelerates Data Platform Push

Ceragem's new ISO/IEC report sets international standards for integrating home healthcare devices, focusing on user well-being and safety.

Hugel Participates AMWC ASIA & TDAC 2026 at the Taipei International Convention Center, Taiwan

Hugel targets Taiwan's aesthetic market, showcasing products at AMWC ASIA & TDAC 2026, while expanding in Indonesia with educational programs.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Seers Signs $14.7 Million Contract with UAE to Supply 105,000 Units over 3 Years

Seers signs a major deal for mobiCARE devices in the UAE, aiming for 50% growth and expansion into Vietnam and beyond.
Latest

Next-Gen Cancer Drug Nesuparib: How It Outperforms Olaparib in SCLC and Pancreatic Cancer

Onconic Therapeutics will present Nesuparib research at AACR 2026, showcasing its potential for various cancers and overcoming PARP inhibitor limitations.

Unlock Healthier Hair: JW Shinyak’s Ducray Neoptide Expert Shows 93.6% User Satisfaction in Global Study

JW Shinyak's Ducray Neoptide Expert shows significant hair improvement in a global trial, with high user satisfaction across ages and conditions.

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

Unlocking Weight Loss: How GB102 Probiotics Enhance GLP-1 Obesity Drugs

GI Longevity's GB102 probiotic enhances weight loss with GLP-1 medications, reducing rebound gain and improving blood sugar control.

YH35995: A Game-Changer for Gaucher Disease? FDA Grants Orphan Drug Designation

Yuhan Corp's YH35995 for Gaucher disease receives orphan drug designation, enhancing its development for rare diseases with unmet needs.

Neurophet Unveils AI-Powered Alzheimer’s Treatment Software at ITEM 2026 in Japan

Neurophet showcases AI-driven brain disease tech at ITEM 2026 in Japan, partnering with Hokuyaku Takeyama to expand market reach.

AI vs. Traditional Methods: Discover the Game-Changing Clinical Environment Simulator for Medical Evaluations

A new Clinical Environment Simulator (CES) evaluates medical AI in realistic settings, enhancing safety without risking patient lives.

Pet7 Launches Innovative Probiotic: A Comprehensive Guide for Dog Owners

Cha Bio F&C launches Pet7 Gut Care Probiotics to enhance canine digestive health with a blend of probiotics, prebiotics, and enzymes.

Revolutionizing Regenerative Medicine: How Noul’s AI Blood Analysis is Transforming Stem Cell Treatments

Noul partners with Infinite Medical to enhance its AI blood analysis tool, miLab™ BCM, for stem cell regenerative therapies.

Samjin Pharmaceutical and Ewha Womans University Seoul Hospital Sign MOU for Innovative Migraine Treatment

Samjin Pharmaceutical partners with Ewha Womans University Medical Center to develop treatments for CNS disorders, focusing on migraines.

Lunit’s 200 Billion KRW Funding: How Atinum Investment Boosts AI in Healthcare

Lunit secures 30 billion KRW investment from Atinum to enhance global R&D and operations, reinforcing its position in medical AI.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

ST Pharm Secures Key mRNA-LNP Patent STP1244 in Japan

ST Pharm secures a patent in Japan for its mRNA delivery technology, enhancing its global market position and IP portfolio.

How is Omlyclo Revolutionizing Allergy Treatment in Europe: Key Successes and Insights

Celltrion's Omlyclo treatment is rapidly gaining market share in Europe, winning tenders and expanding prescriptions across multiple countries.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.